Xencor, Inc. is a company in the U.S. stock market and it is a holding in 68 U.S.-traded ETFs. XNCR has around 9.9M shares in the U.S. ETF market. The largest ETF holder of XNCR is the iShares Core S&P Small-Cap ETF (IJR), with approximately 3.08M shares. Investors may also find of interest that the ETF with the largest allocation to XNCR stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 3.36%. On average, U.S. ETFs allocate 0.25% of XNCR to their portfolios.
Additionally, XNCR is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with XNCR as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.93%.